The nation of Zimbabwe has declined a significant US healthcare agreement worth $367m (272 million pounds) spanning five years because of Washington's request for confidential biological samples.
This rejection became public after a official document from December was disclosed, which showed Head of State Emmerson Mnangagwa deemed the arrangement was "skewed".
An official representative has since clarified that the US was demanding access to biological samples for research and profit while refused to guarantee the benefits from future vaccines.
"We are forced to start the difficult and regrettable task of scaling back our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had donated over $1.9bn as health assistance to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has called for continued dialogue to find a deal suitable to both sides so the nation's critical HIV treatment initiative can be sustained.
Broader Implications
This rejection follows a comparable situation in neighbouring Kenya, where a high court blocked a related health funding agreement following concerns were raised about the safety of citizens' medical information.
Since resuming office last year, US President Donald Trump has drastically cut overseas assistance and closed the key foreign aid agency.
USAID had administered assistance for the American government, but Trump argued its expenditure was "inefficient" and his administration was seeking government-to-government deals to boost openness and responsibility.
As per reports, 16 nations in Africa have so far agreed to similar agreements, constituting over $18.3bn in new funding.
Details of the Declined Agreement
The money for Zimbabwe was intended to funded "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this collaboration could have provided immense advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently on antiretroviral therapy through US-supported programmes," Tremont added.
However, government spokesperson Nick Mangwana argued the arrangement was "unfair".
"The proposal required Zimbabwe to share its biological resources and data for a long time, with no corresponding promise of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could result from that provided information," he stated.
"In essence, our nation would supply the raw materials for scientific discovery with no certainty that the end products would be available to our people should a future disease outbreak emerge."
National Interest and International Frameworks
He also said that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were upending frameworks previously established via the international organization.
Mangwana cited its Pandemic Benefit-Sharing system designed to manage future global health emergencies.
"This mechanism is intended to ensure that when a nation provides its information, the benefits – such as vaccines and treatments – are shared equitably, not commercialised solely by those with the capability to create them."
These objections over the US deal "are not meant as opposition to America," Mangwana stressed.
"We welcome further dialogue with our US partners on how subsequent co-operation could be arranged in a way that respects the sovereignty and interests of each country."
Health Experts Reaction
A leading public health body stated it understood the official position, but urged that negotiations should continue considering a large portion of the nation's Aids initiatives depended on international support.
"If technical issues arise, including those involving data governance or agreement terms, these can frequently be addressed via technical clarification and mutually agreed protections," the group commented.
This impasse underscores the complex tensions between accepting vital foreign assistance and protecting national sovereignty in an increasingly interconnected world.